Mauna Kea Technologies SA announced that it has received 2.3 million in a round of funding on May 31, 2023. The transaction included participation from new investor Tasly Pharmaceutical Group Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.408 EUR | -0.49% | +2.00% | -13.38% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
15.81 CNY | -0.44% | +2.26% | 3.27B | ||
0.408 EUR | -0.49% | +2.00% | 27.04M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.38% | 27.04M | |
-16.33% | 18.62B | |
-42.18% | 2.85B | |
+22.02% | 1.94B | |
+0.39% | 1.68B | |
+27.15% | 1.26B | |
-10.70% | 1.03B | |
-18.27% | 938M | |
+0.66% | 783M | |
-25.07% | 628M |
- Stock Market
- Equities
- ALMKT Stock
- News Mauna Kea Technologies
- Mauna Kea Technologies SA announced that it has received €2.3 million in funding from Tasly Pharmaceutical Group Co., Ltd